Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Werner syndrome ATP-dependent helicase (WRN) is a multifunctional enzyme crucial for maintaining genome stability. It functions as a DNA helicase and exonuclease, participating in DNA replication, repair, recombination, and telomere maintenance. Mutations in WRN cause Werner syndrome, a disorder characterized by premature aging and increased cancer risk. WRN is also a therapeutic target in certain cancers, particularly MSI-H tumors.
Loss or inhibition of WRN leads to cell death, especially in MSI-H tumors.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Werner Syndrome ATP-dependent Helicase (WRN).